Molecular Imaging of Late Somatostatin Receptor–Positive Metastases of Renal Cell Carcinoma in the Pancreas by Radiolabeled 111In SRS Octreotide Scan : A Rare Differential Diagnosis to Multiple Primary Pancreatic Neuroendocrine Tumors
#1565
Introduction: Somatostatin-Receptor Scintigraphy (SRS) has a sensitivity and specificity for pancreatic NETs (pNETs) of 90 and 80% respectively. SRS is indicated as first staging procedure and one of the most sensitive imaging modalities for well-differentiated neuroendocrine tumors, based on imaging of somatostatin receptors (SSRTs).
Aim(s): To report 111In SRS scan ability in detecting lesions of RCC origin.
Materials and methods: A radiolabeled 111In SRS scan was used.
Conference: 13th Annual ENETSConcerence (2016)
Presenting Author: Dimitriadis G
Authors: Dimitriadis G, Davies L, Randeva H, Weickert M,
Keywords: SRS, pNET, SSRTs, RCC,
To read the full abstract, please log into your ENETS Member account.